ABSTRACT: Introduction: Electrophysiological measurements are used in longitudinal clinical studies to provide insight into the progression of amyotrophic lateral sclerosis (ALS) and the relationship between muscle weakness and motor unit (MU) degeneration. Here, we used a similar longitudinal approach in the Cu/Zn superoxide dismutase (SOD1[G93A]) mouse model of ALS. Methods: In vivo muscle contractility and MU connectivity assays were assessed longitudinally in SOD1(G93A) and wild type mice from postnatal days 35 to 119. Results: In SOD1(G93A) males, muscle contractility was reduced by day 35 and preceded MU loss. Muscle contractility and motor unit reduction were delayed in SOD1(G93A) females compared with males, but, just as with males, muscle contractility reduction preceded MU loss. Discussion: The longitudinal contractility and connectivity paradigm employed here provides additional insight into the SOD1(G93A) mouse model and suggests that loss of muscle contractility is an early finding that may precede loss of MUs and motor neuron death.
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting approximately 5 in 100,000 individuals. 1, 2 The disease is characterized by progressive loss of upper and lower motor neurons resulting in weakness, muscle denervation and atrophy, and eventual death, typically within 3-5 years of symptom onset.
Electrophysiological measures, including compound muscle action potential (CMAP) and motor unit number estimate (MUNE), allow in vivo assessment of the motor unit (MU) connectivity. Such measurements have been applied in clinical natural history studies of ALS to provide important insight into the interrelationship of muscle function and MU connectivity. [3] [4] [5] [6] [7] A powerful aspect of CMAP and MUNE measurements is that the functional status of the neuromuscular system can be tracked longitudinally to identify disease onset, severity, and rate of progression. Furthermore, MUNE can assess the response of the neuromuscular system to a therapeutic intervention from the standpoint of preservation or regeneration of MU number as well as increased output from individual MUs (i.e., compensatory collateral reinnervation). [8] [9] [10] Several clinical studies have leveraged electrophysiological measures to gain pathophysiological insight into longitudinal disease progression, including the timing and rate of MU loss, the ability of individual MUs to develop collateral sprouting, and the relationship between MU degeneration and onset of muscle weakness. 4, 7, [11] [12] [13] Dantes and McComas 4 demonstrated 50% losses of MUs 6 months after initial screening, followed by a rapid reduction in MUNE over 1 year-nearly halving every 6 months-before reduction slowed over the next 18 months. This study also demonstrated a corresponding increase in the single motor unit potential (SMUP) amplitude, consistent with reinnervation by collateral axonal sprouting of surviving MUsprobably explaining why patients might present with absent or mild muscle weakness despite such a dramatic reduction in MUNE. Another early clinical study by Yuen and Olney 7 measured CMAP and MUNE in addition to functional grip strength in 10 patients with ALS over the course of 6 months. They reported a significant reduction in MUNE at 3 and 6 months after initial screening and single-fiber electromyography (SFEMG) revealed increased mean fiber density of the abductor digiti minimi. During this time, CMAP and grip strength did not reduce, which the authors argued was evidence for the compensatory ability of remaining motor neurons via collateral sprouting. Clinical studies that track the natural history of MU integrity during ALS provide several useful insights, including potential treatment windows and underlying dynamic biological processes that could not otherwise be studied. [14] [15] [16] [17] Overexpression of human Cu/Zn superoxide dismutase (SOD1) with a G93A mutation (SOD1 [G93A])was used to develop the first mouse model of ALS in 1994. 18, 19 Several studies have investigated neuromuscular function in the SOD1(G93A) mouse model using either electrophysiological or physiological measures. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Several cross-sectional disease progression studies of MU dysfunction are of particular interest. [21] [22] [23] 32 Hegedus and colleagues 21 demonstrated fast-twitch MU loss as early as postnatal day 40 (P40) using in situ muscle contractile measurements. Mancuso and colleagues 32 also demonstrated presymptomatic CMAP amplitude reduction by P56. 32 One of the challenges to understanding the presymptomatic changes that occur in the MU has been the difficulty of following the relationships between physiological (muscle contractility; twitch torque, and tetanic torque) and electrophysiological (MU connectivity; CMAP, and MUNE) measures in individual animals over the course of the disease in a way that mimics the longitudinal clinical studies performed in humans. We recently applied methodology to perform in vivo longitudinal assessments in mouse models of neuropathy, 33 spinal muscular atrophy, 34, 35 and aging. 36 Here, we applied these methods to the SOD1(G93A) mouse.
MATERIALS AND METHODS
Animals. All procedures were performed in accordance with National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the institutional animal care and use committee of The Ohio State University. In total, 54 mice were used in this study for reliability testing and for the longitudinal analysis of disease progression in the SOD1 (G93A) mouse model. Adult wild type (WT) and SOD1(G93A; C57BL/6xSJL/J; No: 002726) mice used for longitudinal studies and pathology were obtained from The Jackson Laboratory (Bar Harbor, Maine). Wild type C57BL/6 mice used for intrarater reliability testing were obtained from Taconic Biosciences (Albany, New York). All procedures were performed with blinded raters.
Procedures.
Behavioral Assessments. Body weight was recorded prior to performing grip strength and rotarod. 37, 38 For grip strength, the average right hind limb grip strength, measured in grams, was calculated from 5 measurements per assessment by using a standard grip meter (DEFII-002; Chatillon, Largo, Florida). Mice were positioned to allow only the right hind paw to grasp the grid and were pulled toward the evaluator for the length of the grip meter. 39 Attempts that were ≥ ±10 g different from the other attempts were discarded and re-performed. The average of 3 motor coordination tests was measured by using an accelerating rotarod (LE8205; Panlab Harvard Apparatus, Barcelona, Spain) starting at 5 revolutions per min. Trials were stopped when 120 s passed without a fall.
Anesthesia and Animal Preparation. Mice were anesthetized (isoflurane inhalation, 1.5%-3%) during electrophysiological and muscle physiological recordings. Lubricant ointment was applied to the eyes to prevent corneal drying. All measurements were performed on the right hind limb, which was shaved with electric clippers prior to studies. Electrophysiological procedures were performed on a heated platform (World Precision Instruments, Sarasota, Florida) set at 37 C. During muscle contractility procedures, a warm water bath HTP-1500 heat therapy pump (Androit Medical Systems, Loudon, Tennessee) set at 37 C was used to maintain temperature of the testing stage. Procedures under anesthesia were typically less than 20 min.
Electrophysiology. Compound muscle action potential and MUNE were recorded as previously described. 34, 35, 40 Briefly, an active ring electrode was placed superficially over the right triceps surae (gastrocnemius and soleus), and a reference ring electrode (Alpine Biomed, Skovlunde, Denmark) was placed superficially over the metatarsals of the right hind paw. A ground electrode (Carefusion, Middleton, Wisconsin) was placed on the tail. The sciatic nerve was stimulated (0.1-ms pulse, 1-10-mA intensity) by using 2 insulated monopolar needles (28G, Teca; Oxford Instruments Medical, Hawthorne, New York). Compound muscle action potential amplitudes were recorded after supramaximal stimulation (20-mV sensitivity, 10-HZ low filter, 10-kHZ high filter). Baseline-to-peak amplitudes were used for comparison of CMAP amplitudes, and peak-to-peak amplitudes were used for calculation of MUNE. Single motor unit potential was calculated by taking the average of 10 incremental submaximal responses (50-500 μV sensitivity, 10 HZ low filter, 10 kHZ high filter). Motor unit number estimation was calculated by dividing the average SMUP amplitude (peak-to-peak) into the maximum peak-to-peak CMAP amplitude. Single-fiber electromyography was recorded as previously described in a separate cohort of SOD1(G93A) males (n = 3 animals, 19 single-muscle fiber action potentials) and WT males (n = 3 animals, 13 single-muscle fiber action potentials) at P35. 41 Muscle Contractility. After electrophysiological recordings, mice underwent triceps surae plantarflexion torque assessment with an in vivo muscle contractility apparatus (Model 1300A; Aurora Scientific, Aurora, Ontario, Canada; Supp. Info. Fig. 1 , Supp. Info. Methods) as previously detailed. 36 Briefly, the right hind paw was taped to the force sensor and positioned at 90
. The hind limb was extended to position the knee in the locking position and secured at the femoral condyles. Two disposable monopolar electrodes (Natus Neurology, Middleton, Wisconsin) were inserted near the tibial nerve, just posterior to the knee. Maximum plantarflexion twitch torque was recorded after a single, supramaximal stimulation (200-μs square wave pulse). Maximum tetanic contraction torque was assessed after a train of supramaximal square wave stimulations of 200-μs duration delivered at 125-HZ stimulation frequency.
Neuromuscular Junction Imaging and Quantitation. To investigate the morphological correlates of loss of muscle contractility and reduced MU connectivity, the soleus muscle was collected from a separate cohort of SOD1(G93A) (3 males/3 females) and WT (3 males/3 females) mice for endpoint studies at P70 and fixed in 4% paraformaldehyde at room temperature (RT) for 30 min. 42, 43 Muscles were teased into fibers by using size 55 forceps (Fine Science Tools, North Vancouver, British Columbia, Canada) and then incubated in blocking buffer (10% goat serum/4% bovine serum albumin/3% Triton-X 100/phosphate-buffered saline [PBS]) at RT for 2 h. An overnight primary antibody (α-NF-200, 1:5,000, Ab72996; Abcam, Cambridge, Massachusetts) incubation at 4 C was performed, followed by three 10-min washes with PBS before receiving a 2-h incubation with secondary antibody (Alexa Fluor 594 goat α-chicken, 1:1,000, A11042; Life Technologies, Grand Island, New York) and α-α-bungarotoxin-488 (1:1,000, B13422; Life Technologies) at RT. Samples then underwent three 10-min washes with PBS at RT before being mounted onto Superfrost positively charged glass slides (Fisher Scientific, Pittsburg, Pennsylvania) and sealed with Fluoromount-G (Southern Biotech, Birmingham, Alabama). Samples were imaged at ×20 and ×40 with a confocal microscope (DM IRE2; Leica, Wetzlar, Germany) with Leica software (version 2.1). Images were viewed in FIJI (LOCI; University of Wisconsin-Madison, Madison, Wisconsin) to quantitate NMJ innervation, the colabeling of NF-200, and α-bungarotoxin. Ninety-five to 120 NMJs per muscle sample (per mouse) were scored as fully innervated, partially innervated, or denervated.
Experiments.
Intrarater Testing. Intrarater reliability was assessed for electrophysiology and muscle contractility. Sixteen WT mice (C57BL/6J; 7 males and 9 females) were assessed by an observer (CGW), with 1 day between trials. Reliability was reported by using the intraclass correlation coefficient (ICC), which was defined as poor (ICC ≤ 0.5), moderate (0.5 < ICC ≤ 0.75), good (0.75 < ICC ≤ 0.9), or excellent (ICC > 0.9). Mice that displayed loss of the righting reflex for 30 s were humanely killedfor tissue harvesting and muscle wet weight recording. 45 Additional SOD1(G93A) (n = 6) and WT (n = 6) mice were killed at P70, and right triceps surae muscles were collected, weighed, and processed for NMJ quantitation. A single evaluator (C.G.W.) performed the longitudinal electrophysiological and muscle contractility.
Statistical Analysis. Intrarater variability analyses were used to assess the degree of agreement between the electrophysiology and muscle contractility across all mice, over time. Analyses were performed in the R package irr (R version 3.3.2, The R Foundation for Statistical Computing, Vienna, Austria).
A mixed-effects model was used to model the mean of each of the 6 outcome variables for the longitudinal experiments. Fixed effects were included for the 2 groups, SOD1 mutants and WT, and sex. A random intercept was used to account for repeated measures within mouse. Backward selection was used starting from an initial model with up to 3-way interactions. A square root transformation was used for CMAP, SMUP, and MUNE. Furthermore, a quadratic time trend was included for CMAP, MUNE, and normalized twitch torque. Group means were compared at each time point at the 0.05 level by using Holm's method to adjust for multiplicity within each outcome. 46 When group effects differed significantly by sex, comparisons were made within each sex. Analysis was performed in SAS 9.4 (SAS Institute, Cary, North Carolina). Unpaired t test was performed in Prism version 6 (GraphPad Software, La Jolla, California) to compare jitter, muscle weight, and NMJ quantitation. Pearson's correlation coefficients were calculated to determine correlations between muscle contractility and MU connectivity, behavioral measurements and muscle contractility, and behavioral measurements and MU connectivity. Correlation coefficient strengths were interpreted according to prior guidelines: negligible (0.0 ≤ r ≤ 0.3), weak (0.3 < r ≤ 0.5), moderate (0.5 < r ≤ 0.7), strong (0.7 < r ≤ 0.9), and very strong (0.9 < r ≤ 1.0). 47 Statistical significance was set at P < 0.05. Muscle contractility and MU connectivity were assessed longitudinally from P35 to P119 in SOD1 (G93A) (5 males/5 females) and WT (5 males/5 females) mice (Tables 1, 2 ). Mixed-effects models for longitudinal muscle contractility and MU connectivity reduction were used from P35 to P119 in separate cohorts of male and female mice ( Figs. 1, 2 ; Supp. Info. Tables 1, 2 ). Reduced muscle contractility preceded MU connectivity reduction in both male and female SOD1(G93A) mice. Normalized twitch torque in SOD1 (G93A) There was no observed sexual dimorphism in SMUP, with increases occurring at P70 for both SOD1 (G93A) males and females (252.0 μV, 95% CI: 236.6-267.9 μV) relative to WT males and females (218.7 μV, 95% CI: 204.3-233.5 μV; Fig. 2C ). Singlefiber EMG was performed to exclude the possibility that failure of NMJ transmission could be the explanation for early contractility reduction in SOD1 mice. Separate cohorts of SOD1(G93A) males and WT males were studied with SFEMG in the gastrocnemius at P35 to assess NMJ integrity. There was no difference in jitter between SOD1(G93A) males (8.02 ± 2.29 μs; range, 4.01-12.27) and WT males (8.38 ± 2.45 μs; range, 5.07-12.57; P = 0.669). Table 3 summarizes and compares onset of MU degeneration and reduced muscle contractility.
RESULTS
Muscle Atrophy Occurs After Loss of Muscle Contractility.
We assessed wet triceps surae muscle mass (normalized to body mass) to examine whether the early findings of reduced muscle contractility and loss of MU connectivity were associated with coexistent loss of muscle mass. Separate groups of WT and SOD1 (G93A) were killed at P70 in addition to the longitudinal cohorts at P119, and their right triceps surae muscles were harvested and weighed (Fig. 3) . There was no change in the relative percentage of denervated soleus NMJs between SOD1(G93A) and WT mice at P70 (Supp. Info. Fig. 2 ). Despite reduction of both muscle contractility and MU connectivity, there were no overt differences in normalized triceps surae wet mass at P70 between WT and SOD1(G93A) mice (Fig. 3A) . At P119, normalized triceps surae wet mass was reduced in SOD1(G93A) mice compared with WT mice (Fig. 3A) . When we organized normalized triceps surae wet mass by sex at P70, there was no difference in normalized triceps surae mass between SOD1(G93A) males relative to WT males, nor was there difference between SOD1(G93A) females and WT females (Fig. 3B) . At P119, normalized triceps surae mass was reduced in SOD1(G93A) males compared with WT males as well as in SOD1(G93A) females compared with WT females (Fig. 3B) .
Correlations Between MU Connectivity, Muscle Contractility, and Behavioral Assessments. Correlations were analyzed between electrophysiological measures, muscle contractility, and grip strength at week 15. Motor unit number estimation showed a very strong positive correlation with absolute twitch torque and absolute tetanic torque (Fig. 4A,C) , but MUNE showed no significant correlation with normalized twitch and tetanic torque (Fig. 4B,D) . Compound muscle action potential demonstrated a strong positive correlation with both absolute twitch torque (r = 0.84, P < 0.01) and absolute tetanic torque (r = 0.76, P < 0.05) and a moderately positive correlation with both normalized twitch torque (r = 0.68, P < 0.05) and normalized tetanic torque (r = 0.65, P < 0.05; not shown). Grip strength was strongly correlated with CMAP (r = 0.82, P < 0.01) and MUNE (r = 0.71, P < 0.05) and moderately correlated with absolute twitch torque (r = 0.66, P < 0.05; not shown). There was no significant correlation for grip compared with absolute tetanic torque (r = 0.579, P = 0.079), normalized twitch torque (r = 0.513, P = 0.130), or normalized tetanic torque (r = 0.516, P = 0.127; not shown).
DISCUSSION
In the SOD1(G93A) mouse model, overt behavioral disease onset is typically observed at approximately P90. 18, 57 However, behavioral measurements used in SOD1(G93A) mice are limited in their ability to measure directly and accurately MU integrity. A number of physiological and pathological cross-sectional studies that directly assess the MU demonstrated earlier phenotypic features relative to typical behavioral disease onset. 20, 21, 23, 32, 58 Fast-fatigable muscles have increased vulnerability to denervation and are less efficient at maintaining NMJ collateral reinnervation. 58 In situ contractility analyses of isolated fastfatigable muscles by Hegedus and colleagues 21 demonstrated MU loss and corresponding contractile weakness in male mice as early as P40. In our study, we similarly identified reduction of muscle contractility as early as P35 using noninvasive muscle contractility measurements. In contrast to prior studies, muscle contractility was assessed in the intact triceps surae muscle, which includes the gastrocnemius, a muscle predominantly composed of fast-fatigable muscle fibers, and the soleus, predominantly composed of slow-fatigue resistant muscle fibers. Using intact muscle groups with mixed muscle fiber types closely mirrors clinical muscle testing in patients in which multiple muscles are tested together. 59 Our results show that reduced contractility occurs before reduction of MU connectivity in both SOD1 (G93A) males and females. It is important to note that in vivo muscle contractility measurements require intact and functioning motor axons, NMJs, and muscle excitability contraction coupling. Therefore, it was important to consider whether early NMJ degeneration might explain early twitch and tetanic muscle contraction torque losses. We found that several results in our study argued against this possibility. First, we assessed NMJ transmission using SFEMG which is the most sensitive measure of NMJ transmission in vivo. 41 Single-fiber EMG at P35 (when the twitch and tetanic muscle contractions were reduced) was unchanged in mutant versus WT male mice. Furthermore, twitch and CMAP responses were both measured after a single supramaximal nerve stimulation, and our results showed that reduced twitch occurred prior to CMAP was reduced in both SOD1(G93A) males and females by 7 and 28 days, respectively. Together, the discrepant twitch and CMAP findings along with our SFEMG results support excitation-contraction decoupling and not NMJ transmission failure as the cause of early contractility reduction. Finally, if muscle contractility precedes MU connectivity reduction, we would expect also to see no muscle atrophy related to denervation. In our studies, wet muscle weight did not reveal triceps surae (gastrocnemius and soleus) atrophy at P70 when muscle contractility was already reduced, suggesting that loss of muscle contractility was not simply related to muscle size.
Our findings of early reduction of muscle contractility (prior to SFEMG abnormalities and CMAP and MUNE reduction) suggest early subsarcolemmal abnormalities resulting in excitation-contraction decoupling. Prior studies have suggested muscle specific defects in ALS patients and SOD1(G93A) mice. [60] [61] [62] [63] Increased oxidative stress in the sarcolemma and the sarcoplasmic reticulum have also been observed in SOD1(G93A) mice. 63, 64 The increased oxidative stress may result in muscle excitation- contraction decoupling, possibly through abnormalities of calcium regulation, myofilament function, or adenosine triphosphate (ATP) production. 64, 65 One protein critical for excitation-contraction coupling, which may be negatively impacted to produce early contractile reduction, is sarcoplasmic reticulum Ca 2+ ATPase. Sarcoplasmic reticulum Ca 2+ ATPase pump activity is diminished after increased oxidative stress, with the intracellular Ca 2+ imbalances resulting in muscle contractile weakness. 66, 67 Sexual dimorphism observed in our studies is consistent with previous reports that SOD1(G93A) males exhibit earlier disease onset compared with their female counterparts in C57BL/6xSJL/J mice. 55, 56 Sex differences appear to be background strain specific. Male SOD1(G93A) mice on the strain used in this work (C57BL/6xSJL/J) as well as SJL mice have been shown to present earlier symptom onset compared with females, whereas male SOD1(G93A) on C57BL/6 exhibit no sex differences. 55 A previous study used mice generated from SOD1(G93A) C57BL/6xSJL/6 that were crossed with WT C57BL/6 mice and demonstrated no sex-specific differences in MU number loss or in muscle contractile force deficits. 22 The potential differences in the background strains of SOD1(G93A) mice used may account for the discrepant results.
Our paradigm is strengthened by the capacity for repeat measures of muscle contractility and MU connectivity in individual animals. Previous studies of MU reduction in SOD1(G93A) mice were performed via a cross-sectional paradigm. [21] [22] [23] 32 Although such crosssectional analyses allow examination of aggregate differences over time, they do not permit consideration of disease trajectories of individual mice. Using a longitudinal approach allowed us to assess disease progression in individual mice over time and legitimize the approach to use statistical modeling of the disease time course to properly account for heterogeneity between mice. Our results suggest that longitudinal assessments of in vivo muscle contractility in conjunction with MU connectivity may be a powerful readout for preclinical drug testing in this model as well as in other models of neuromuscular disease.
The development of meaningful outcome measures for ALS is critically important. The methodology for measuring muscle contractility presented here as a physiological outcome measure shares qualities of a good physiological biomarker in that it is reproducible, minimally invasive, and easy to obtain and has the capacity to make longitudinal measures. 68 Rater reliability results are in line with intrarater reliabilities of muscle function and MU connectivity measurements in clinical studies (ICCs ranging from 0.55 to 0.99) [48] [49] [50] [51] [52] [53] and preclinical studies that used MU connectivity measurements in mice (ICCs ranging from 0.56 to 0.76). 54 Muscle contractility measurements after nerve stimulation could be performed alongside current strength tests in people with ALS, such as with hand-held dynamometers, with the added benefit of not being impacted by the strength of the evaluator. 69 In conclusion, when muscle contractility measurements are combined with longitudinal MU connectivity measurements, this allows a more complete analysis of MU innervation and functional status in degenerative models. Early muscle contractility dysfunction occurred prior to MU connectivity deficits and may precede neuronal death in SOD1(G93A) mice. Therefore, the design and execution of preclinical studies with SOD1(G93A) mice can be enhanced through this paradigm. Moreover, we believe that muscle contractility outcome measures have the potential to be applied directly in patients to detect early changes in contractility.
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